Despite the mechanisms underlying AD onset remain puzzling, scientific efforts suggest that Aβ and phosphorylated tau are important triggers, mediators and aggravators of AD pathology, acting in both separate and synergistic ways to the degenerative events that occur in AD brain [33,34,35]. This evidence concerns the gene MAPT and Alzheimer disease.